Evidence map›Paper›PMID 40624459›Full record

ArticleBMC infectious diseases2025

Dynamics of respiratory virus transmission in children during and after COVID-19 outbreak control in Baiyin, China.

Biao Wang, Hui Zhang, Shu Liang, Huan Wei, Miao Wang, Huimin Zhang, Xiaoshu Zhang, Maoxing Dong

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Biao WangLab for viruses, Gansu Provincial Center for Disease Control and Prevention, Lanzhou, 730000, China.
Hui ZhangLab for viruses, Gansu Provincial Center for Disease Control and Prevention, Lanzhou, 730000, China.
Shu LiangLab for viruses, Gansu Provincial Center for Disease Control and Prevention, Lanzhou, 730000, China.
Huan WeiLab for viruses, Gansu Provincial Center for Disease Control and Prevention, Lanzhou, 730000, China.
Miao WangLab for viruses, Gansu Provincial Center for Disease Control and Prevention, Lanzhou, 730000, China.
Huimin ZhangLab for viruses, Gansu Provincial Center for Disease Control and Prevention, Lanzhou, 730000, China.
Xiaoshu ZhangLab for viruses, Gansu Provincial Center for Disease Control and Prevention, Lanzhou, 730000, China. zhxs222@126.com.
Maoxing DongLab for viruses, Gansu Provincial Center for Disease Control and Prevention, Lanzhou, 730000, China. dongmx2005@hotmail.com.

Funding

Gansu Provincial Health Industry Science and Technology Innovation Major Project GSWSKY2024-022Gansu Provincial Key Research and Development Program-Social Development Field Program Project 23YFFA0051
6 · The paper itself

Abstract

purposeWe aimed to study the changes in respiratory virus detection rates during the control of the COVID-19 outbreak and to elucidate possible epidemiologic disturbances after the lifting of control measures.

methodsSevere acute respiratory infection (SARI) specimens were collected from hospitalized children in Baiyin, China, from 2021 to 2023. We conducted real-time fluorescence quantitative PCR (RT-qPCR) to detect various respiratory viruses, including influenza virus (IFV), human respiratory syncytial virus (HRSV), human rhinovirus (HRV), human parainfluenza virus (HPIV), human metapneumovirus (HMPV), human adenovirus (HADV), enterovirus (EV), and human coronavirus (HCoV). The results were statistically analyzed using SPSS 26.0 software.

resultsA total of 1353 nasopharyngeal swab specimens were collected from children with SARI between 2021 and 2023. The male-to-female ratio of 1.49:1, the total virus detection rate of 33.85% (458/1353). Data were analyzed by comparing two distinct periods: before the lifting of the COVID-19 control measures (January 1, 2021 - December 6, 2022) and after the lifting of the control measures (December 7, 2022 - December 31, 2023). During the three-year study period, there was no significant difference in the detection rate of pathogen positivity between the ≤ 1 year (OR: 0.986, 95% CI: 0.960-1.013) and 1-3 years (OR: 1.018, 95% CI: 0.997-1.060) age groups (P > 0.05). However, there were significant differences in pathogen positivity rates between the 3-6 years (OR: 1.097, 95% CI: 1.049-1.146) and > 6 years (OR: 1.099, 95% CI: 1.063-1.138) age groups (P < 0.05). Significant differences in pathogen positivity rates were observed between male (OR: 1.293, 95% CI: 1.156-1.445) and female (OR: 1.354, 95% CI: 1.157-1.583) children (P < 0.05). The positive detection rates for various viruses showed a decreasing trend in January and February 2023; however, IFV showed a significant rebound in 2023. Following the lifting of COVID-19 control measures, the overall positive detection rate for respiratory viruses increased significantly from 27.84 to 45.03% (OR: 1.313, 95% CI: 1.198-1.438) (P < 0.05). Prior to the lifting of control measures, the ranking of positive detection rates for respiratory viruses in children was as follows: HPIV > HRSV > HADV > HRV > HMPV > EV > HCOV > influenza virus (IFV). After the measures were lifted, the order was as follows: EV > IFV > HADV > HCOV > HPIV > HRV > HMPV > HRSV. The peak detection periods for HRV, HMPV, HADV, and EV shifted to later time points compared to those before the measures were lifted. After the lifting of control measures, the positive detection rates of IFV (OR: 1.090, 95% CI: 1.059-1.122), EV (OR: 1.102, 95% CI: 1.064-1.141), HCOV (OR: 1.043, 95% CI: 1.017-1.070), and HADV (OR: 1.028, 95% CI: 0.999-1.059) all significantly increased (P < 0.05); HRV (OR: 1.019, 95% CI: 0.994-1.044) and HMPV (OR: 1.010, 95% CI: 0.989-1.032) showed non-significant increases in positive detection rates (P > 0.05); HRSV (OR: 0.965, 95% CI: 0.946-0.985) was significantly reduced (P < 0.05), while the positive detection rate for HPIV (OR: 0.971, 95% CI: 0.943-1.001) showed no significant decrease(P > 0.05).

conclusionsThese findings help clarify that social interventions can influence the prevalence of respiratory viruses in children during unique historical periods. The implementation of COVID-19 control measures may have curbed the spread of respiratory viruses in children during the study period. After the lifting of control measures, monitoring of respiratory pathogens must be strengthened to reduce the harm caused by respiratory viruses to children's health.

Indexed as

COVID-19Respiratory Tract InfectionsAdolescentChildChild, PreschoolChinaDisease OutbreaksFemaleHumansInfantMaleNasopharynxSARS-CoV-2ChildrenCoronavirus disease 2019Preventive and control measuresRespiratory viruses

Identifiers

PMID40624459
PMCPMC12235979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.